Embla Medical hf (Embla Medical hf) LT-Debt-to-Total-Asset : 0.31 (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Embla Medical hf LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Embla Medical hf's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.31.

Embla Medical hf's long-term debt to total assets ratio declined from Mar. 2023 (0.32) to Mar. 2024 (0.31). It may suggest that Embla Medical hf is progressively becoming less dependent on debt to grow their business.

Embla Medical hf LT-Debt-to-Total-Asset Historical Data

The historical data trend for Embla Medical hf's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embla Medical hf LT-Debt-to-Total-Asset Chart

Embla Medical hf Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.31

0.37

0.31

0.30

0.31

Embla Medical hf Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.32	0.31	0.31	0.31	0.31

Embla Medical hf LT-Debt-to-Total-Asset Calculation

Embla Medical hf's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	424.407	/	1385.682
	=	0.31

Embla Medical hf's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	475.58	/	1545.132
	=	0.31

Embla Medical hf (OTCPK:OSSUY) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Embla Medical hf LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Embla Medical hf's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Embla Medical hf (Embla Medical hf) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embla Medical hf (OTCPK:OSSUY) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

OSSFF:USA OSSR:Denmark

Address

Grjothals 5, Reykjavik, ISL

Website

https://www.ossur.com

Ossur hf is engaged in the design, development, manufacture, and sale of prosthetics and bracing & support products. The company's products improve mobility through technologies in the field of braces, supports, prosthetic limbs, and compression therapy. Its segments are the Bracing & Supports and Prosthetics segment. The bracing & support products are used to support joints and other body parts for therapeutic and preventative purposes. The Prosthetics segment includes artificial limbs and related products for individuals born without limbs. Its geographical segments are the Americas; Europe, the Middle East & Africa (EMEA); and the Americas & Asia-Pacific (APAC), of which the Americas generate nearly half of the company's revenue.